000 | 01778 a2200517 4500 | ||
---|---|---|---|
005 | 20250515235333.0 | ||
264 | 0 | _c20101122 | |
008 | 201011s 0 0 eng d | ||
022 | _a1097-4598 | ||
024 | 7 |
_a10.1002/mus.21743 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMorine, Kevin J | |
245 | 0 | 0 |
_aActivin IIB receptor blockade attenuates dystrophic pathology in a mouse model of Duchenne muscular dystrophy. _h[electronic resource] |
260 |
_bMuscle & nerve _cNov 2010 |
||
300 |
_a722-30 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 |
_aActivin Receptors, Type II _xantagonists & inhibitors |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 | _aCloning, Molecular |
650 | 0 | 4 |
_aCreatine _xblood |
650 | 0 | 4 |
_aCreatine Kinase _xblood |
650 | 0 | 4 |
_aDependovirus _xgenetics |
650 | 0 | 4 | _aEchocardiography |
650 | 0 | 4 | _aHeart Function Tests |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred mdx |
650 | 0 | 4 | _aMice, Transgenic |
650 | 0 | 4 |
_aMuscle Contraction _xdrug effects |
650 | 0 | 4 |
_aMuscle, Skeletal _xgrowth & development |
650 | 0 | 4 |
_aMuscular Dystrophy, Duchenne _xdrug therapy |
650 | 0 | 4 |
_aMyostatin _xphysiology |
650 | 0 | 4 |
_aOrgan Size _xdrug effects |
650 | 0 | 4 | _aSignal Transduction |
650 | 0 | 4 |
_aTransforming Growth Factor beta _xphysiology |
700 | 1 | _aBish, Lawrence T | |
700 | 1 | _aSelsby, Joshua T | |
700 | 1 | _aGazzara, Jeffery A | |
700 | 1 | _aPendrak, Klara | |
700 | 1 | _aSleeper, Meg M | |
700 | 1 | _aBarton, Elisabeth R | |
700 | 1 | _aLee, Se-Jin | |
700 | 1 | _aSweeney, H Lee | |
773 | 0 |
_tMuscle & nerve _gvol. 42 _gno. 5 _gp. 722-30 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/mus.21743 _zAvailable from publisher's website |
999 |
_c20066293 _d20066293 |